Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
Authors:
- 6 September 2020
- journal article
- research article
- Published by Springer Nature in Experimental Brain Research
- Vol. 238 (11) , 2603-2614
Abstract
Neuronal dysfunction and loss are thought to be one of the causes of cognitive impairment in Alzheimer's disease (AD), but the specific mechanism of neuronal loss in the pathogenesis of AD remains controversial. This study explored the role of NLRP3 inflammasome-induced neuronal pyroptosis in neuronal loss of AD, and pioneered the use of NLRP3 inhibitor MCC950 to intervene in the treatment of senescence-accelerated mouse prone 8 (SAMP8) mice. In vitro, human primary neurons (HPNs) pretreated with MCC950 were stimulated with amyloid-β1–42 (Aβ1–42), and it was found that MCC950 significantly reduced the neurotoxicity of Aβ1–42 by inhibiting neuronal pyroptosis. In vivo, SAMP8 mice were randomly divided into vehicle-treated group and MCC950-treated group, and it was found that MCC950 also played a positive role in treatment. The intervention of MCC950 improved the spatial memory ability and brain histological morphology of SAMP8 mice, and reduced the deposition of amyloid-β in the brain. Furthermore, MCC950 was found to inhibit the overexpressions of NLRP3, caspase-1, and GSDMD, which were the response factors of pyroptosis in SAMP8 mouse neurons, by immunofluorescence staining. In this study, we found that neuronal pyroptosis induced by the NLRP3/caspase-1/GSDMD axis was an important factor in neuronal loss of AD, and revealed that MCC950 might be a potential AD therapeutic agent.Keywords
Funding Information
- National Natural Science Foundation of China (81671623, 81873880, 81501417)
- Medical Scientific Research Foundation of Guangdong Province (No. A2017296)
This publication has 57 references indexed in Scilit:
- Acupuncture promotes expression of Hsp84/86 and delays brain ageing in SAMP8 miceAcupuncture in Medicine, 2019
- Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer's disease: Modulation of hippocampal neurogenesis and apoptosis as underlying mechanismProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2019
- Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activityJournal of Experimental Medicine, 2018
- Honey is cytotoxic towards prostate cancer cells but interacts with the MTT reagent: Considerations for the choice of cell viability assayFood Chemistry, 2018
- TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's diseaseInternational Immunopharmacology, 2018
- The road to restoring neural circuits for the treatment of Alzheimer's diseaseNature, 2016
- mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathiesAging Cell, 2013
- Elevated Oxidative Stress in the Brain of Senescence-accelerated Mice at 5 Months of AgeBiogerontology, 2006
- Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM)Mechanisms of Ageing and Development, 2005
- The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's diseaseExperimental Gerontology, 2005